Francisco Partners has invested in Therapeutic Research Center. Financial terms weren’t disclosed. Stockton, Calif.-based Therapeutic Research provides drug therapy recommendations, continuing education, training, and data to the healthcare community. Berkery, Noyes & Co. served as the financial advisor to Therapeutic Research.
Aug 13, 2012 – Francisco Partners, a leading technology-focused private equity firm, today announced that it has completed a strategic investment in Therapeutic Research Center, a leading provider of drug therapy recommendations, continuing education, training, and data to the healthcare community.
“We see a growing need for reliable information for healthcare professionals as advances in technology and a growing patient population combine to make the practice of medicine increasingly complex,” said Chris Adams, a principal with Francisco Partners. “Therapeutic Research Center is one of the most trusted platforms in healthcare, and we look forward to supporting the company in its continued growth.”
Founded in 1985, Therapeutic Research Center conducts extensive research to synthesize the frequently changing and often unclear data on drug therapy into clear, concise, and unbiased recommendations for medical professionals. The company offers a broad portfolio of drug therapy advisory services, including Pharmacist’s Letter, Prescriber’s Letter, and Pharmacy Technician’s Letter. The company also offers an extensive set of accredited continuing education programs.
“We founded Therapeutic Research Center with the mission of providing healthcare professionals with high-quality, unbiased information and recommendations that improve patient care and patient outcomes,” said Jeff Jellin, founder and editor-in-chief of Therapeutic Research Center. “Francisco Partners’ deep technology expertise will help us incorporate new technology and tools to better inform and educate healthcare professionals and help achieve our core mission.”
Shearman & Sterling LLP acted as legal advisor to Francisco Partners. Berkery, Noyes & Co. served as the financial advisor to Therapeutic Research Center, and Choate Hall and Stewart LLP provided legal counsel to the company.
About Francisco Partners
Francisco Partners is a global private equity firm that specializes in investments in technology and technology-enabled services companies. Since its launch over a decade ago, FP has invested in more than 100 technology companies, making it one of the most active investors in the industry. The firm invests in transactions where its deep sub-sector knowledge and operational expertise can help companies realize their full potential. For further information, please visit: www.franciscopartners.com.
About Therapeutic Research Center
Therapeutic Research Center is a research, analytic, and information services organization that provides evidence-based drug therapy recommendations for physicians, pharmacists, pharmacy technicians, and other healthcare professionals. The company also provides information on natural medicines to institutions and individual consumers. Therapeutic Research Center’s leading information products include Pharmacist’s Letter, Prescriber’s Letter, Pharmacy Technician’s Letter, Natural Medicines Comprehensive Database, Ident-A-Drug Reference, and a variety of continuing education and training courses. The company also operates Pharmacy Technicians University, an online education platform focused on the training and certification of pharmacy technicians. Therapeutic Research Center is fully accredited by every major continuing education accrediting agency for physicians, pharmacists, nurse practitioners, and physician assistants. For further information, please visit: www.therapeuticresearch.com.